Effects of Chronic Cocaine and Ethanol Self-administration on Brain Dopamine Receptors in a Rhesus Monkey Model of Polysubstance Abuse
Overview
Authors
Affiliations
Most individuals with cocaine use disorder also use alcohol; however, little is known about the behavioural and pharmacological mechanisms that promote co-abuse. For example, although studies in humans and animals have documented that chronic use of either alcohol or cocaine alone decreases D2-like receptor (D2R) availability, effects of co-abuse of these substances on dopamine receptor function have not been characterized. These studies examined the effects of long-term cocaine self-administration in 12 male rhesus monkeys who also consumed either ethanol or an ethanol-free solution each day (n = 6 per group). Specifically, all monkeys self-administered cocaine (0.1 mg/kg per injection) 5 days per week in the morning. In the afternoon, six monkeys consumed 2.0 g/kg ethanol over 1 h to model binge drinking and six monkeys drank an ethanol-free solution. Assessment of D2R availability using positron emission tomography (PET) and [ C]raclopride occurred when monkeys were drug-naïve and again when monkeys had self-administered approximately 400-mg/kg cocaine. D R function was assessed at the same time points by determining the potency of the D R-preferring agonist quinpirole to elicit yawns. Chronic cocaine self-administration decreased D2R availability in subregions of the basal ganglia in control monkeys, but not those that also drank ethanol. In contrast, D R sensitivity increased significantly after chronic cocaine self-administration in ethanol-drinking monkeys but not controls. These results suggest that co-use of ethanol substantially changes the effects of chronic cocaine self-administration on dopamine receptors, specifically implicating D R as a target for medications in these individuals.
Prete J, Collier M, Epperly P, Czoty P Drug Alcohol Depend. 2024; 260:111347.
PMID: 38833794 PMC: 11186377. DOI: 10.1016/j.drugalcdep.2024.111347.
Fitzgerald N, Liu Y, Wang A, Striley C, Setlow B, Knackstedt L Drug Alcohol Depend. 2024; 258:111272.
PMID: 38555662 PMC: 11793138. DOI: 10.1016/j.drugalcdep.2024.111272.
Uruena-Mendez G, Dimiziani A, Belles L, Goutaudier R, Ginovart N Int J Mol Sci. 2023; 24(17).
PMID: 37686044 PMC: 10487888. DOI: 10.3390/ijms241713238.
Czoty P, Tryhus A, Solingapuram Sai K, Nader S, Epperly P Brain Res. 2023; 1807:148323.
PMID: 36914041 PMC: 10150948. DOI: 10.1016/j.brainres.2023.148323.
Say F, Tryhus A, Epperly P, Nader S, Solingapuram Sai K, George B Addict Biol. 2022; 27(5):e13219.
PMID: 36001440 PMC: 9413385. DOI: 10.1111/adb.13219.